P C Hoffman

1.2k total citations
46 papers, 975 citations indexed

About

P C Hoffman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, P C Hoffman has authored 46 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in P C Hoffman's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). P C Hoffman is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). P C Hoffman collaborates with scholars based in United States, France and United Kingdom. P C Hoffman's co-authors include Harvey M. Golomb, Mark K. Ferguson, Everett E. Vokes, C Skosey, Gregory A. Masters, David W. Fraser, Charles U. Mauney, Francis Robicsek, D. Haraf and Ann M. Mauer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

P C Hoffman

45 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P C Hoffman United States 16 570 552 201 146 141 46 975
H. Evin Gulbahce United States 20 228 0.4× 364 0.7× 377 1.9× 122 0.8× 234 1.7× 63 928
F. Vaylet France 12 618 1.1× 466 0.8× 66 0.3× 133 0.9× 81 0.6× 96 848
Anne‐Marie Maddox United States 10 399 0.7× 469 0.8× 57 0.3× 191 1.3× 50 0.4× 18 754
Akimasa Sekine Japan 18 862 1.5× 303 0.5× 267 1.3× 83 0.6× 98 0.7× 130 1.1k
Soichiro Ikushima Japan 13 439 0.8× 106 0.2× 150 0.7× 80 0.5× 80 0.6× 32 724
Mathew Simcock Switzerland 18 127 0.2× 272 0.5× 188 0.9× 214 1.5× 137 1.0× 46 926
Steven Gans Netherlands 12 638 1.1× 481 0.9× 108 0.5× 190 1.3× 31 0.2× 20 941
Kyosuke Tanaka Japan 19 674 1.2× 313 0.6× 130 0.6× 118 0.8× 750 5.3× 117 1.3k
Hae‐Seong Nam South Korea 11 265 0.5× 95 0.2× 148 0.7× 53 0.4× 56 0.4× 32 498
Feriyl Bhaijee United States 18 127 0.2× 256 0.5× 161 0.8× 130 0.9× 319 2.3× 57 820

Countries citing papers authored by P C Hoffman

Since Specialization
Citations

This map shows the geographic impact of P C Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P C Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P C Hoffman more than expected).

Fields of papers citing papers by P C Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P C Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P C Hoffman. The network helps show where P C Hoffman may publish in the future.

Co-authorship network of co-authors of P C Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of P C Hoffman. A scholar is included among the top collaborators of P C Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P C Hoffman. P C Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juloori, Aditya, Christine M. Bestvina, Sean P. Pitroda, et al.. (2021). RO01.01 Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis. Journal of Thoracic Oncology. 16(1). S45–S45. 1 indexed citations
2.
Koshy, Matthew, Philip P. Connell, Everett E. Vokes, et al.. (2017). Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 98(1). 247–247. 1 indexed citations
3.
Shumway, Dean A., Kimberly S. Corbin, Ravi Salgia, et al.. (2011). Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 74(3). 446–450. 16 indexed citations
4.
Ferko, A, et al.. (2006). A modified radiofrequency-assisted approach to right hemihepatectomy. European Journal of Surgical Oncology. 32(10). 1209–1211. 14 indexed citations
5.
Herbst, Roy S., Diane Prager, Róbert Hermann, et al.. (2004). TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7011–7011. 40 indexed citations
6.
Mauer, Ann M., Rafat Ansari, P C Hoffman, et al.. (2003). Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer. Annals of Oncology. 14(5). 722–728. 3 indexed citations
7.
Cohen, Ezra E.W., P C Hoffman, Ann M. Mauer, et al.. (2000). Phase I study of carboplatin and vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer. Lung Cancer. 29(1). 105–106. 1 indexed citations
8.
Shammo, Jamile M., et al.. (1999). First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 39(8). 838–844. 15 indexed citations
9.
Fleming, Gini F., J. W. Kugler, P C Hoffman, et al.. (1998). Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.. Journal of Clinical Oncology. 16(6). 2032–2037. 16 indexed citations
10.
Mauer, Ann M., Gregory A. Masters, D. Haraf, et al.. (1998). Phase I study of docetaxel with concomitant thoracic radiation therapy.. Journal of Clinical Oncology. 16(1). 159–164. 129 indexed citations
11.
Masters, Gregory A., Daniel J. Haraf, P C Hoffman, et al.. (1998). Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.. Journal of Clinical Oncology. 16(6). 2157–2163. 41 indexed citations
12.
Hoffman, P C, et al.. (1998). Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysis. Annals of Oncology. 9(6). 647–651. 11 indexed citations
13.
Masters, Gregory A., et al.. (1997). Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 15(3). 884–892. 17 indexed citations
14.
Vokes, Everett E., et al.. (1997). Ifosfamide-based chemotherapy for non-small cell lung cancer: Phase I/II studies at the University of Chicago. Lung Cancer. 16(2-3). 276–276. 3 indexed citations
15.
Hoffman, P C, Gregory A. Masters, S Krauß, et al.. (1996). Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study. Annals of Oncology. 7(3). 314–316. 15 indexed citations
16.
Hoffman, P C, Gregory A. Masters, S Krauß, et al.. (1996). Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.. PubMed. 23(3 Suppl 6). 11–5. 3 indexed citations
17.
Vokes, Everett E., Daniel J. Haraf, P C Hoffman, et al.. (1995). A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemotherapy and Pharmacology. 35(4). 304–312. 6 indexed citations
18.
Larson, Richard A., et al.. (1990). Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.. PubMed. 4(2). 127–31. 2 indexed citations
19.
Hoffman, P C, et al.. (1981). Metastatic non-small cell bronchogenic carcinoma: A randomized trial of sequential versus combination chemotherapy. Clinical research. 29(4). 1 indexed citations
20.
Hoffman, P C, et al.. (1981). Two Outbreaks of Sternal Wound Infections Due to Organisms of the Mycobacterium fortuitum Complex. The Journal of Infectious Diseases. 143(4). 533–542. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Evin Gulbahce Breakdown of academic impact, for papers by F. Vaylet Breakdown of academic impact, for papers by Anne‐Marie Maddox Breakdown of academic impact, for papers by Akimasa Sekine Breakdown of academic impact, for papers by Soichiro Ikushima Breakdown of academic impact, for papers by Mathew Simcock Breakdown of academic impact, for papers by Steven Gans Breakdown of academic impact, for papers by Kyosuke Tanaka Breakdown of academic impact, for papers by Hae‐Seong Nam Breakdown of academic impact, for papers by Feriyl Bhaijee
Rankless by CCL
2026